Effects of the calciotrophic peptides calcitonin and parathyroid hormone on prostate cancer growth and chemotaxis

Prostate

Volumn 30, Issue 3, 1997, Pages 183-187

  Ritchie, Candace K ^a   Thomas, Kris G ^a   Andrews, Laura R ^a   Tindall, Donald J ^b   Fitzpatrick, Lorraine A ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

calcitonin; DU 145 cells; LNCaP cells; parathyroid hormone; PC3 cells; proliferation

Indexed keywords

CALCITONIN; PARATHYROID HORMONE;

ARTICLE; BONE METASTASIS; CANCER GROWTH; CELL PROLIFERATION; CHEMOTAXIS; DOSE RESPONSE; GROWTH REGULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; MALE; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROSTATE CANCER;

CALCITONIN; CARCINOMA; CELL DIVISION; CHEMOTAXIS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; PARATHYROID HORMONE; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030996618     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970215)30:3<183::AID-PROS6>3.0.CO;2-N     Document Type: Article

References (22)

1. Chiarodo A: National Cancer Institute roundtable on prostate cancer: Future research directions. Cancer Res 51:2498-2505, 1991.
2. Glaves D: Mechanisms of metastasis: Prostate cancer. Prog Clin Biol Res 239:329-345, 1987.
3. Ishibe M, Rosier RN, Puzas JE: Human prostatic acid phosphatase directly stimulates collagen synthesis and alkaline phosphatase content of isolated bone cells. J Clin Endocrinol Metab 73:785-792, 1991.
4. Raisz LG, Kream BE: Regulation of bone formation. N Engl J Med 309:29-35, 1983.
5. Slovik DM, Rosenthal DI, Doppelt SH: Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25 dihydroxyvitamin D. J Bone Miner Res 1:377-381, 1986.
6. 3[H]-thymidine incorporation and alkaline phosphatase activity in human osteoblast-line cells. Calcif Tissue Int 48:297-301, 1991.
7. 45Ca uptake and alters alkaline phosphatase specific activity in human osteosarcoma cells. Metab Clin Exp 42:97-104, 1993.
8. 2+ transients. Endocrinology 134: 596-602, 1994.
9. Horosezewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP: LNCaP model of human prostatic carcinoma. Cancer Res 43:1809-1818, 1983.
10. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF: Isolation of a human prostate carcinoma cell line (DU145). Int J Cancer 21:274-281, 1978.
11. Kaign ME, Narayan KS, Ohnuki Y, Lechner J, Jones LW: Establishment and characterization of a human prostatic cancer cell line (PC-3). Invest Urol 17:16-23, 1979.
12. Ritchie CK, Maercklein PB, Fitzpatrick LA: Direct effect of calcium channel antagonists on osteoclast function: Alterations in bone resorption and intracellular calcium concentrations. Endocrinology 135:996-1003, 1994.
13. Bradford MM: A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976.
14. Campbell PB: An improved method for the in vitro evaluation of monocyte leukotaxis. J Lab Clin Med 90: 381-388, 1977.
15. Malone JD, Teitelbaum SL, Griffin GL, Senior RM, Kahn AJ: Recruitment of osteoclast precursors by purified bone matrix constituents. J Cell Biol 92:227-230, 1982.
16. Shah GV, Noble MJ, Austenfeld M, Weigel J, Deftos LJ, Mebust WK: Presence of calcitonin-like immunoreactivity (iCT) in human prostate gland: Evidence for iCT secretion by cultured prostate cells. Prostate 21:87-97, 1992.
17. Reginster JY, Deroisy R, Fontaine MA, Franchimont P: Influence of estrogen replacement therapy on endogenous calcitonin production rates. Gynecol Endocrinol 6:65-71, 1992.
18. Silver J, Naveh-Many T: Calcitonin gene regulation in vivo. Hormone Metab Res 25:470-472, 1993.
19. Lazaretti-Castro M, Grauer A, Mekonnen Y, Raue F, Ziegler R: Effects of 17 beta-estradiol on calcitonin secretion and content in a human medullary thyroid carcinoma cell line. J Bone Miner Res 6:1191-1195, 1991.
20. Orloff JJ, Wu TL, Stewart AF: Parathyroid hormone-like proteins: Biochemical responses and receptor interactions. Endocr Rev 10:476-495, 1989.
21. Iwamura M, di Sant' Agnese PA, Wu G, Benning CM, Cockett ATK, Deftos LJ, Abrahamsson P-A: Immunohistochemical localization of the parathyroid hormone-related protein in human prostate cancer. Cancer Res 53:1724-1726, 1993.
22. Iwamura M, Wu G, Abrahamsson P-A, Cockett ATK, Foss KA, Deftos LJ: Parathyroid hormone-related protein: A potential autocrine growth regulator in human prostate cancer cell lines. Urology 44:675-679, 1994.